UnitedHealth [UNH] vs CVS Health [CVS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: UnitedHealth Group Incorporated wins in 14 metrics, CVS Health Corporation wins in 7 metrics, with 0 ties. UnitedHealth Group Incorporated appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | UnitedHealth Group Incorporated | CVS Health Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.81 | 55.65 | UnitedHealth Group Incorporated |
| Price-to-Book Ratio | 3.42 | 1.31 | CVS Health Corporation |
| Debt-to-Equity Ratio | 73.98 | 106.06 | UnitedHealth Group Incorporated |
| PEG Ratio | -0.27 | 0.72 | CVS Health Corporation |
| EV/EBITDA | 17.29 | 11.48 | CVS Health Corporation |
| Profit Margin (TTM) | 2.68% | 0.44% | UnitedHealth Group Incorporated |
| Operating Margin (TTM) | 8.05% | 1.57% | UnitedHealth Group Incorporated |
| EBITDA Margin (TTM) | 8.05% | 1.57% | UnitedHealth Group Incorporated |
| Return on Equity | 12.18% | 2.29% | UnitedHealth Group Incorporated |
| Return on Assets (TTM) | 3.78% | 2.47% | UnitedHealth Group Incorporated |
| Free Cash Flow (TTM) | $16.08B | $7.81B | UnitedHealth Group Incorporated |
| Dividend Yield | 3.84% | 3.23% | UnitedHealth Group Incorporated |
| 1-Year Return | 30.30% | 51.14% | CVS Health Corporation |
| Price-to-Sales Ratio (TTM) | 0.72 | 0.25 | CVS Health Corporation |
| Enterprise Value | $371.09B | $167.94B | UnitedHealth Group Incorporated |
| EV/Revenue Ratio | 0.83 | 0.42 | CVS Health Corporation |
| Gross Profit Margin (TTM) | 16.34% | 12.84% | UnitedHealth Group Incorporated |
| Revenue per Share (TTM) | $496 | $316 | UnitedHealth Group Incorporated |
| Earnings per Share (Diluted) | $13.24 | $1.39 | UnitedHealth Group Incorporated |
| Beta (Stock Volatility) | 0.41 | 0.51 | UnitedHealth Group Incorporated |
| Short % of Float | 1.86% | 1.56% | CVS Health Corporation |
UnitedHealth Group Incorporated vs CVS Health Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| UnitedHealth Group Incorporated | 0.62% | 1.10% | 4.36% | 43.98% | 20.50% | 22.19% |
| CVS Health Corporation | -1.26% | 3.71% | 5.00% | 32.75% | 26.34% | 25.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| UnitedHealth Group Incorporated | 30.30% | -10.90% | 4.92% | 196.70% | 717.69% | 822.38% |
| CVS Health Corporation | 51.14% | 50.56% | 23.74% | 7.51% | 173.13% | 237.73% |
Performance & Financial Health Analysis: UnitedHealth Group Incorporated vs CVS Health Corporation
| Metric | UNH | CVS |
|---|---|---|
| Market Information | ||
| Market Cap | $322.34B | $101.07B |
| Market Cap Category | Mega cap | Large cap |
| 10 Day Avg. Volume | 9,626,040 | 7,440,168 |
| 90 Day Avg. Volume | 9,353,900 | 7,575,109 |
| Last Close | $411.04 | $100.68 |
| 52 Week Range | $234.60 - $415.98 | $58.50 - $102.77 |
| % from 52W High | -1.19% | -2.03% |
| All-Time High | $630.73 (Nov 11, 2024) | $113.65 (Jul 27, 2015) |
| % from All-Time High | -34.83% | -11.41% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.08% |
| Quarterly Earnings Growth | 0.00% | 0.79% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.00% |
| Operating Margin (TTM) | 0.08% | 0.02% |
| Return on Equity (TTM) | 0.12% | 0.02% |
| Debt to Equity (MRQ) | 73.98 | 106.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $103.87 | $59.18 |
| Cash per Share (MRQ) | $34.32 | $8.33 |
| Operating Cash Flow (TTM) | $23.15B | $10.64B |
| Levered Free Cash Flow (TTM) | $17.69B | $5.93B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.84% | 3.23% |
| Last 12-Month Dividend | $10.94 | $2.68 |
Valuation & Enterprise Metrics Analysis: UnitedHealth Group Incorporated vs CVS Health Corporation
| Metric | UNH (Apr 26, 2026) | CVS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.81 | 55.65 |
| Forward P/E | 17.17 | 9.45 |
| PEG Ratio | -0.27 | 0.72 |
| Price to Sales (TTM) | 0.72 | 0.25 |
| Price to Book (MRQ) | 3.42 | 1.31 |
| Market Capitalization | ||
| Market Capitalization | $322.34B | $101.07B |
| Enterprise Value | $371.09B | $167.94B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.83 | 0.42 |
| Enterprise to EBITDA | 17.29 | 11.48 |
| Risk & Other Metrics | ||
| Beta | 0.41 | 0.51 |
| Book Value per Share (MRQ) | $103.87 | $59.18 |
Financial Statements Comparison: UnitedHealth Group Incorporated vs CVS Health Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | UNH (2025) | CVS (2025) |
|---|---|---|
| Revenue/Sales | 447.57B | 402.07B |
| Cost of Goods Sold | 364.65B | 346.71B |
| COGS % of Revenue | 81.5% | 86.2% |
| Gross Profit | 82.92B | 55.36B |
| Gross Margin | 18.5% | 13.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 18.96B | 10.39B |
| Operating Margin | 4.2% | 2.6% |
| EBITDA | 23.33B | 15.10B |
| EBITDA Margin | 5.2% | 3.8% |
| Pre-Tax Income | 14.70B | 2.14B |
| Pre-Tax Income % of Revenue | 3.3% | 0.5% |
| Income Tax | 1.89B | 408.00M |
| Income Tax % of Revenue | 0.4% | 0.1% |
| Net Income (Profit) | 12.81B | 1.73B |
| Profit Margin | 2.9% | 0.4% |
Balance Sheet & Liquidity Metrics
| Metric | UNH (2025) | CVS (2025) |
|---|---|---|
| Cash & Equivalents | 24.37B | 8.45B |
| Total Current Assets | 90.58B | 74.71B |
| Total Current Assets % of Revenue | 20.2% | 18.6% |
| Total Current Liabilities | 114.90B | 88.69B |
| Total Current Liabilities % of Revenue | 25.7% | 22.1% |
| Long-Term Debt | 72.32B | 74.15B |
| Long-Term Debt % of Revenue | 16.2% | 18.4% |
| Total Shareholders Equity | 101.70B | 75.38B |
| Retained Earnings | 95.60B | 61.20B |
| Retained Earnings % of Revenue | 21.4% | 15.2% |
| Property, Plant & Equipment | 0 | 14.97B |
Cash Flow Statement Comparison
| Metric | UNH (2025) | CVS (2025) |
|---|---|---|
| Operating Cash Flow | 13.61B | 5.15B |
| Operating Cash Flow % of Revenue | 3.0% | 1.3% |
| Capital Expenditures | -3.62B | -2.83B |
| Free Cash Flow | 16.08B | 7.81B |
| FCF Margin | 3.6% | 1.9% |
| Debt Repayment | -3.05B | -5.75B |
| Common Stock Repurchase | -5.55B | 0 |
Short Interest & Institutional Ownership Analysis
| Metric | UNH | CVS |
|---|---|---|
| Shares Short | 15.18M | 19.89M |
| Short Ratio | 1.68 | 2.56 |
| Short % of Float | 1.86% | 1.56% |
| Shares Outstanding | 905.84M | 1.27B |
| Float Shares | 902.31M | 1.27B |
| % Held by Insiders | 0.81% | 0.07% |
| % Held by Institutions | 83.96% | 90.07% |
| % Held by Public | 15.23% | 9.86% |
Dividend Analysis & Yield Comparison: UnitedHealth Group Incorporated vs CVS Health Corporation
| Metric | UNH | CVS |
|---|---|---|
| Last 12-Month Dividend | $10.94 | $2.68 |
| Last 12-Month Dividend Yield | 3.84% | 3.23% |
| 3-Year Avg Annual Dividend | $8.25 | $2.61 |
| 3-Year Avg Dividend Yield | 0.50% | 0.97% |
| 3-Year Total Dividends | $24.76 | $7.83 |
| Ex-Dividend Date | Mar 09, 2026 | Jan 22, 2026 |